AstraZeneca (AZN) Executive in China Under Investigation

Author's Avatar
Oct 30, 2024
Article's Main Image

AstraZeneca's (AZN, Financial) China division reported that Wang Lei, the company's Global Executive Vice President, President of International Business, and Head of China operations, is currently assisting with an investigation in China. Despite this development, AstraZeneca's China operations continue to function smoothly under the leadership of the current General Manager. The company has pledged full cooperation with the investigation as required.

Disclosures

I/We may personally own shares in some of the companies mentioned above. However, those positions are not material to either the company or to my/our portfolios.